This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Uranium Resources, Ener1: Volume Movers

Stocks in this article: URRE HEV

NEW YORK ( TheStreet) -- Uranium Resources (URRE) was one of several stocks poised to move on above-average volume Wednesday after a court ruling in the company's favor.

Uranium Resources said late Tuesday that the U.S. Court of Appeals for the Tenth Circuit ruled that the company's Section 8 property in Churchrock, New Mexico is not Indian Country, which clears the way for Uranium Resources to pursue a permit with New Mexico to advance its uranium mining project.

"URI will continue to hold discussions with concerned stakeholders including members of the Navajo Nation, but the court's decision allows us to move forward," Uranium Resources CEO Don Ewigleben said in a statement.

Shares of Uranium Resources surged by 34 cents, or 68%, to 84 cents in the premarket session. The 50-day average daily volume for Uranium Resources is 249,000, according to the Nasdaq.

Elsewhere, Power-One (PWER) jumped by 52 cents, or 6.8%, to $8.14 in the premarket session after the power management solutions company said late Tuesday it has completed its two-step reorganization, merging into New Power-One.

The surviving company retains the Power-One name and stock symbol, as well as business, operations, assets and liabilities, although Power-One's rights plan, or "poison pill," has been terminated. The 50-day average daily share volume for Power-One is 2.26 million.

Immunomedics (IMMU) rose by 20 cents, or 5.8%, to $3.64 in the premarket session after the company said its experimental lupus drug epratuzumab "provided significant efficacy" in a mid-stage trial. Treatment differences were observed as early as week 8, with further improvement to week 12, Immunomedics said the data showed. The 50-day average daily volume for Immunomedics is 877,000.

Both Synovus Financial (SNV) and Sterling Bancshares (SBIB) may see an increase in trading volume after Credit Suisse analysts assigned neutral ratings to both stocks. Credit Suisse had previously rated Synovus with an underperform rating and had no coverage on Sterling Bancshares.

Synovus shares closed Tuesday at $2.83 and were flat in the premarket session. Sterling Bancshares finished Tuesday's session at $5.21.

Meanwhile, Ener1 (HEV) continued to rally, up 14.6% to $3.92 early Wednesday after climbing 12.5% Tuesday. Needham analysts initiated coverage of the battery systems for energy storage company's stock with a buy rating, citing growing demand for lithium-ion batteries. The three-month average daily volume for Ener1 is 740,000, according to Yahoo! Finance.

-- Written by Robert Holmes in Boston.

Check out all of Wednesday's high-volume, under-$5 stocks at the Dollar Store. View the Dollar Store portfolio on StockPickr.

Follow Robert Holmes on Twitter and become a fan of on Facebook.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,457.50 +100.63 0.58%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs